Navigation Links
Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
Date:9/16/2008

ORMD 0901 is Being Developed as an Oral Dosage Form of a GLP1-analog Aimed

at Improving Glycemic Control in Adults With Type 2 Diabetes

JERUSALEM, Israel, September 16 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB), a developer of oral drug delivery systems, announced today that it has launched pre-clinical trials of ORMD 0901, a GLP1-analog.

ORMD 0901 belongs to the Incretin family of drugs which helps to manage diabetes, including reduction in blood glucose levels and inhibiting glucagon secretion.

Incretins have been cited in causing regeneration of pancreatic insulin secreting cells, and in tissue protective properties including protection of the heart. GLP1 and analogs are associated with gradual weight loss, which is very desirable in diabetes patients.

"The launch of pre-clinical trials of ORMD 0901 and expansion of Oramed's platform marks the next strategic milestone for our company as we demonstrate the effectiveness of our oral delivery technology in yet another important family of polypeptide drugs for diabetes, that are until now only available in injection form," said Oramed CEO Nadav Kidron.

We plan to conduct the ORMD 0901 trials at Hadassah University Medical Center and they are expected to conclude by the end of 2008.

Oramed plans to launch phase 2b trials of ORMD 0801, its oral insulin capsule, in India in the first quarter of 2009.

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are b
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
2. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
3. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... CHICAGO , July 31, 2015 ... Composition Analyzers Market by Product (Bioimpedance Analyzers (BIA), Dual-Energy ... and Hydrostatic Weighing) - Global Analysis & Forecast to ... Market was pegged at $911.1 Million 2014 and is ... at a CAGR of 9.4% from 2014 to 2019. ...
(Date:7/31/2015)... , July 31, 2015 ... solutions for video, data and cloud computing operators ... a leading pharma giant for Internet of Things ... IoT applications offered on subscription model. ... Pharma giant is striving for business innovations to ...
(Date:7/30/2015)... 30, 2015 Edwards Lifesciences Corporation (NYSE: EW ... and hemodynamic monitoring, today announced that Robert A. Ingram ... "Bob is an ardent champion for innovation in the ... have him on Edwards, board as we pursue our focused ... and CEO.  "Bob has provided a valuable perspective to our ...
Breaking Medicine Technology:Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2
... WARSAW, Ind., April 12, 2011 Zimmer Holdings, Inc. (NYSE: ... quarter 2011 sales and earnings conference call will be broadcast ... 8:00 a.m. Eastern Time.  A news release detailing the quarterly ... the morning of the conference call. The ...
... April 12, 2011 /PRNewswire-Asia-FirstCall/ -- China Botanic Pharmaceutical ... or the "Company"), a developer, manufacturer and distributor ... ("TCM") in China, today announced that its wholly ... has received official approval to produce water-based mixtures. ...
Cached Medicine Technology:Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2011 Results 2China Botanic Pharmaceutical Approved to Produce Water-Based Mixtures 2China Botanic Pharmaceutical Approved to Produce Water-Based Mixtures 3
(Date:7/31/2015)... ... 31, 2015 , ... A family-run business in Grand Rapids, ... sourced all over the world, then manufactured into specific formulations in northern Michigan. ... highest-quality oils in the industry, which we are bringing to consumers at prices ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Super-Sod wants to ... a Super-Sod Pro Page as the perfect fit for such a goal. ... and articles. The social website is a dynamic site that spreads home and home ...
(Date:7/31/2015)... ... ... India Network Foundation sponsors visitor health insurance program for all non-US ... past 25 years. As India Network offers coverage for all age groups, many elderly ... their children and grand children. India Network specializes in covering pre-existing conditions when ...
(Date:7/31/2015)... ... July 31, 2015 , ... With the recent ... of individuals who remain undiagnosed, treatment options for patients are becoming more prevalent ... CPAP therapy due to its overall lack of comfort and highly invasive nature, ...
(Date:7/30/2015)... ... ... The Venetian on Grace Bay in the Turks & Caicos Islands is pleased to announce ... 40% on their stay while enjoying some of the most beautiful ocean views in the ... a chance to reconnect with loved ones and rediscover one's best self. The sea ...
Breaking Medicine News(10 mins):Health News:Living Pure Essential Oils takes Therepeutic Essential Oil Market by Storm 2Health News:Super-Sod Created a Landscape Profile on Houzz.com for Home Garden Design 2Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 2Health News:India Network Visitor Health Insurance Announces Completion of Food Grains Distribution to Godavari Pushkaram Visitors, Andhra Pradesh, India 3Health News:Oravan Sleep Apnea Device Gains Traction in Sleep Industry 2Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2
... from nagging tinnitus can benefit from internet-based therapy just ... therapy sessions. These are the findings of a German-Swedish ... tried out various forms of therapy over a ten-week ... group therapy sessions was significantly better than that of ...
... March 7 (HealthDay News) -- Exposure to cocaine, tobacco ... score lower on academic tests, according to a new ... with no signs of fetal alcohol syndrome, was associated ... and spelling, Boston University researchers found. The negative ...
... TUESDAY, March 6 (HealthDay News) -- Most stroke patients undergo ... contributes to the rising costs of stroke care in the ... researchers analyzed data from more than 600,000 patients diagnosed with ... that 95 percent of the patients who had MRI scans ...
... 6 (HealthDay News) -- A smoking ban in Scotland ... a new study finds. The nationwide ban on smoking ... analyzed data on preterm delivery and small-for-gestational-age babies born between ... who smoked dropped from more than 25 percent before the ...
... When faced with stressful situations, older adults who sleep poorly ... new study finds. The marker, called interleukin-6 (IL-6), has ... cardiovascular disease, diabetes and psychiatric problems. "Our study suggests ... and what poor sleep may be doing to our physiological ...
... and has many ways of evading the drugs used by oncologists ... , Now, ... advanced form of melanoma gets around an inhibitor, Zelboraf, which targets ... of the melanoma genome that encodes proteins, called the exome, Jonsson ...
Cached Medicine News:Health News:Internet-based therapy relieves persistent tinnitus 2Health News:Fetal Cocaine Exposure May Not Affect Kids' Academics: Study 2Health News:Brain Scans Overused on U.S. Stroke Patients, Study Says 2Health News:Poor Sleep May Impact Stress Response in Older Adults 2Health News:UCLA scientists uncover mechanism for melanoma drug resistance 2Health News:UCLA scientists uncover mechanism for melanoma drug resistance 3
Hypervisor III Central Monitoring System...
For the critical care environment, telemetry, emergency room and other monitoring areas....
The CIC Pro Clinical Information Center brings together vital patient information from multiple monitoring devices....
... is a solution for hospitals, communicating ... signs monitoring. Waveform and numeric data ... simultaneous display of up to 32 ... trends are stored automatically. Alarms provide ...
Medicine Products: